56.2% of patients experienced more than 90% repigmentation with excellent color match. 81.3% of patients experienced at least 50% repigmentation. Repigmentation only occurred after a minimum of 4-5 ...

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has approved the RECELL ® System for the treatment of vitiligo. The ...

Early F‑VASI50 responses were associated with VitiQoL improvement without consistent DLQI separation, reinforcing instrument sensitivity differences for vitiligo-specific burden. By week 104, ...

Please provide your email address to receive an email when new articles are posted on . Repigmentation was maintained up to 60 months in more than 80% of patients with vitiligo who were treated with ...

Patients with vitiligo will now have access to the first ever at-home therapy for skin repigmentation approved by the Food and Drug Administration. Jim Lee, vice president for Incyte’s head ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with vitiligo, treatment with ruxolitinib ...

CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology ...

Vitiligo is an autoimmune skin disease that is characterized by the progressive destruction of melanocytes, which results in disfiguring patches of white depigmented ...

For patients with active nonsegmental vitiligo, treatment often requires a multifaceted approach to achieve meaningful repigmentation. In a recently published phase 2b extension study, adding ...

In both studies, upadacitinib met the coprimary endpoints of T-VASI 50 and F-VASI 75 at week 48 vs placebo. Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in ...

For patients with vitiligo, ruxolitinib cream results in greater repigmentation of lesions compared with vehicle control, according to a study published online Oct. 20 in the New England Journal of ...

NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Mar 14, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specialising in the ...